As the co-founder of Calla Lily Clinical Care, I’m always on the lookout for the latest trends and insights shaping healthcare. And also opportunities to escape my children. Did I mention I have 3 pre-teen/teenagers? Recently, I had the opportunity to attend two distinctly different conferences: PODD (Partnership Opportunities in Drug Delivery) in Boston and …
Calla Lily Clinical Care is delighted to partner with the University of Warwick for this fully funded (incl student stipend) four-year iCASE studentship from September 2025, available as part of Warwick’s MRC-funded Doctoral Training Partnership (DTP). Vaginal microbiota play a key role in women’s reproductive health. Disruption of the normal vaginal microbiome is associated with inflammation …
When one thinks about yeast infections, menopause and fertility support, the conversation usually revolves around pills or injections. But there’s a better, more targeted way to achieve results. The era of blanket treatments is fading. I used to joke that medicine isn’t Burger King–you can’t just have it your way. Except, that’s exactly what is …
We had a great 2 days at the Partnerships in Drug Delivery PODD Conference in Boston with team members Professor Andrew Lewis and Dr Lara Zibners representing Calla Lily. Besides Andy’s well received presentation on our Callavid vaginal drug delivery platform, there were also superb connections made with the wider drug delivery technology community, and …
When we talk about advancements in healthcare, the vagina doesn’t often make it into the conversation. But it should. Hell, it’s standard dinner conversation at my house. The power of the vagina as a vessel for targeted, effective treatment is an emerging trend in women’s health. A trend geared toward smarter, safer, more effective medication …
Many of you know my drive to co-found Calla Lily Clinical Care was driven by my personal journey as a infertility survivor. The memory that remains particularly vivid is the distress caused by the inadequate methods of administering progesterone— whether through injections, pessaries, tablets, or suppositories. Each option (including now rings) has its pros and …
Excited to announce that Calla Lily Clinical Care will be attending the PODD Conference in Boston next week! Our Principal Scientist Andrew Lewis and co-founder Lara Zibners will be showcasing our innovative vaginal drug delivery platform and its numerous applications beginning with pregnancy and fertility, and exploring new partnership opportunities. Stay tuned for updates on …
I had the great honour of meeting with Linda Griffith, Professor of Biological and Mechanical Engineering, and MacVicar Fellow at Massachusetts Institute of Technology, where she leads the MIT Center for Gynepathology Research. I’ve long been inspired by Professor Griffith’s groundbreaking work, and now, with our progress and dedicated team & lab resources in place, …
Our team of experts at Calla Lily Clinical Care understands the challenges, questions, and emotions that come with the path to pregnancy. That’s why we are proud to highlight Tommy’s charity Tommy’s is a leading UK charity doing amazing work researching pregnancy complications and baby loss, including miscarriage, stillbirth, and premature birth. The charity’s work …
Did you know that 3 years ago the UK became the first country in the world to recommend vaginally-administered 400mg progesterone to reduce miscarriages? It is estimated that 150,000 women each year in the UK should be taking progesterone, dubbed the “pregnancy hormone”, to reduce the risk of suffering a miscarriage. For those who didn’t …